WebNov 30, 2024 · 1 indications and usage GRANIX is indicated to reduce the duration of severe neutropenia in adult and pediatric patients 1 month and older with non-myeloid malignancies receiving myelosuppressive anticancer drugs associated with a clinically significant incidence of febrile neutropenia. WebSep 28, 2024 · - Indications, benefits, and guidelines. Estimated risk of febrile neutropenia <20 percent; Special considerations during the COVID-19 pandemic - Use …

STANDARD COMMERCIAL DRUG FORMULARY PRIOR …

WebH. Other diagnoses/indications (must meet 1 and 2): 1. For Neupogen, Nivestym or Granix requests, member meets one of the following (a or b): a. Member must use Zarxio, unless contraindicated or clinically significant adverse effects are experienced; *Prior authorization may be required for Zarxio b. Web1. Is Granix prescribed by or given in consultation with a hematologist or oncologist for the following indication? • Adult and pediatric patients 1 month of age and older with a nonmyeloid malignancy who is receiving myelosuppressive anti-cancer drugs associated with a significant incidence of severe neutropenia with fever cylindrical lamp shades for table lamps

Resources GRANIX® (tbo-filgrastim) injection

WebJun 6, 2024 · Call your doctor at once if you have: stomach pain, back pain; a general ill feeling; signs of a kidney problem--blood in your urine, swelling in your face or … WebThe indications for the medications are consistent with FDA approved indications, CMS coverage guidelines, National Comprehensive Cancer Network ... Granix 300 mcg prefilled syringe – 63459-0910-xx (Teva) Granix 400 mcg prefilled syringe – 63459-0912-xx (Teva) Max Units (per dose and over time): WebIndication. GRANIX is indicated to reduce the duration of severe neutropenia in adult and pediatric patients 1 month and older with non-myeloid malignancies receiving myelosuppressive anticancer drugs … cylindrical knitting kit